Arcutis Biotherapeutics (ARQT) Leases (2020 - 2025)
Historic Leases for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to $4.6 million.
- Arcutis Biotherapeutics' Leases rose 12169.9% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 12169.9%. This contributed to the annual value of $2.0 million for FY2024, which is 1728.08% down from last year.
- Per Arcutis Biotherapeutics' latest filing, its Leases stood at $4.6 million for Q3 2025, which was up 12169.9% from $1.7 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Leases ranged from a high of $4.6 million in Q3 2025 and a low of $1.7 million during Q2 2025
- In the last 5 years, Arcutis Biotherapeutics' Leases had a median value of $2.6 million in 2023 and averaged $2.7 million.
- As far as peak fluctuations go, Arcutis Biotherapeutics' Leases soared by 134646.02% in 2021, and later plummeted by 2011.1% in 2025.
- Arcutis Biotherapeutics' Leases (Quarter) stood at $3.0 million in 2021, then dropped by 10.49% to $2.7 million in 2022, then fell by 13.23% to $2.4 million in 2023, then dropped by 17.28% to $2.0 million in 2024, then soared by 133.85% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $1.7 million for Q2 2025, and $1.8 million during Q1 2025.